NCT00853307View on ClinicalTrials.gov

MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 23, 2009

Primary Completion Date

November 23, 2009

Study Completion Date

January 27, 2011

Conditions
Ovarian Carcinoma
Interventions
DRUG

Alisertib

Alisertib capsules

Trial Locations (1)

07922

Summit Medical Group, Berkeley Heights

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY